← Back to Search

Cancer Vaccine

Education + Text Reminders for Parenting (in HPV Vaccination Uptake) (Edtech-HPV Trial)

N/A

Waitlist Available

Led By Abraham Aragones, MD, MS

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Has a minimum of one child between the ages of 11 and 17 who has not initiated or completed the HPV vaccine seriest (as per the age-recommended timeframe)

21 to 84 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Edtech-HPV Trial Summary

This trial will test a community-based educational program to see if it increases the rate of HPV vaccination completion among children of Mexican Americans, with or without a text message reminder system. The trial will also assess the participants' concerns regarding the impact of COVID-19 on their daily life.

Who is the study for?

This trial is for Spanish-speaking primary caregivers, aged 21-84, of children between 11 and 17 who haven't started or finished the HPV vaccine series. Participants must be Mexican or Mexican-American, own a cell phone with text messaging capabilities, and be willing to receive texts for the study. Those with serious psychiatric or cognitive impairments that affect consent or adherence are excluded.Check my eligibility

What is being tested?

The Edtech-HPV trial is testing whether an educational program about the HPV vaccine can increase vaccination rates among children of Mexican Americans when combined with text message reminders. It's a two-arm study comparing education alone versus education plus reminders.See study design

What are the potential side effects?

Since this trial focuses on education and communication methods rather than medical treatments, there are no direct side effects from interventions like drugs or vaccines. However, participants may experience stress related to COVID-19 concerns addressed in surveys.

Edtech-HPV Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have at least one child aged 11-17 who hasn't started or finished the HPV vaccine series.

Select...

I am between 21 and 84 years old.

Edtech-HPV Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Vaccination completion assessment rate

Edtech-HPV Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Parental Education + Text MessagingExperimental Treatment2 Interventions

Participants will receive parental education on HPV vaccine and the vaccine's benefits plus text messaging reminder.

Group II: Parental EducationActive Control1 Intervention

Participants will receive parental education on HPV vaccine and the vaccine's benefits.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,935 Previous Clinical Trials

588,183 Total Patients Enrolled

Hackensack Meridian HealthOTHER

131 Previous Clinical Trials

27,572 Total Patients Enrolled

Abraham Aragones, MD, MSPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

2 Previous Clinical Trials

184 Total Patients Enrolled

Media Library

HPV Vaccine (Cancer Vaccine) Clinical Trial Eligibility Overview. Trial Name: NCT03209713 — N/A

Parenting Research Study Groups: Parental Education + Text Messaging, Parental Education

Parenting Clinical Trial 2023: HPV Vaccine Highlights & Side Effects. Trial Name: NCT03209713 — N/A

HPV Vaccine (Cancer Vaccine) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03209713 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the overall participant count for this investigation?

"This research endeavour requires 800 eligible participants. Those who meet the inclusion criteria can enroll at REACH in Las Vegas, Nevada or The University of Texas at El Paso in El Paso, Texas."

Answered by AI

What type of individual would be capable of participating in this medical inquiry?

"Prospective members of this clinical study must be between 21 and 84 years old, with at least one child. 800 participants are needed to carry out the trial."

Answered by AI

Are there any opportunities for participants to enroll in this investigation?

"This clinical trial is presently recruiting, per the details available on clinicaltrials.gov. The study was initially published on June 28th 2017 and most recently updated on December 7th 2021."

Answered by AI